DURHAM, North Carolina (March 1, 2011) – Health Decisions, a leading contract research organization in Adaptive Clinical Trials that’s committed to shortening timelines and maximizing value for pharmaceutical, biotech and medical device companies, announced that it received Safe Harbor Certification effective February 15, 2011.
The Safe Harbor designation recognizes Health Decisions meets or exceeds directives of the European Union for data privacy and protection. The Safe Harbor framework was created by the U.S. Department of Commerce in consultation with the Europe Commission’s Directive on Data Protection to bridge differences in countries’ privacy approaches and provide a streamlined means for U.S. organizations to comply with data protection laws.
“Health Decisions has always been committed to protecting the confidentiality and privacy of our customer’s data. This certification affirms that commitment,” said Health Decisions Chief Operating Officer, Alicia Paladin. “We are pleased to be part of a limited group of organizations to be awarded this designation.”
About Health Decisions
Health Decisions is the leading contract research organization (CRO) in Adaptive Clinical Trials committed to shortening development timelines and maximizing pipeline value for pharmaceutical, biotech and medical device companies. Through Agile Clinical Development—a strategic three-pronged approach that combines adaptive design, adaptive operations and proprietary technology — Health Decisions delivers real-time performance metrics that enable sponsors to make the most of competitive market opportunities. Health Decisions is headquartered in Durham, NC, with over twenty years of experience helping sponsors exceed development goals in Phase I-IV clinical trials across all major therapeutic areas. For more information, please visit the company’s website at www.HealthDec.com.
For more information, contact Courtney Cleaves, Marketing Manager at email@example.com.